CoChat

Murine atopic dermatitis responds to peroxisome proliferator-activated receptors α and β/δ (but not γ) and liver X receptor activators

Open access
Hatano, Yutaka, Man, Mao-Qiang, Uchida, Yoshikazu, Crumrine, Debra, Mauro, Theodora M., Feingold, Kenneth R., Elias, Peter M., Holleran, Walter M. · 2010 · Journal of Allergy and Clinical Immunology
Cited by 88

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background Atopic dermatitis (AD) is a chronic inflammatory dermatosis now increasingly linked to mutations that alter the structure and function of the stratum corneum (SC). Activators of peroxisome proliferators-activated receptor (PPAR)α, β/δ, γ and liver-X-receptor (LXR) regulate epidermal protein and lipid production, leading to superior barrier function. Additionally, some of these activators exhibit potent anti-hyperplastic and anti-inflammatory activity in irritant contact dermatitis and acute allergic contact dermatitis mouse models. Objective We evaluated the efficacy of PPAR/LXR activation in a hapten (oxazolone [Ox])-induced atopic dermatitis-like model (Ox-AD) in hairless mice. Methods Ox-AD was established with ten Ox challenges (every-other day) on the flank. After the establishment of Ox-AD, twice daily topical application with individual PPAR/LXR activators was then performed for 4 days, with continued Ox challenges every other day. The efficacy of topical PPAR/LXR activators to reduce parameters of Ox-AD was assessed physiologically, morphologically and immunologically. Results Certain topical activators of PPARα, PPARβ/δ, and LXR, but not activators of PPARγ, reversed the clinical dermatosis, significantly improved barrier function, and increased SC hydration in Ox-AD mice. In addition, the same activators, but again not PPARγ, largely reversed the immunologic abnormalities in Ox-AD mice, including the elevated TH2 markers, such as tissue eosinophil/mast cell density, serum TARC levels, density of CRTH2-positive lymphocytes (but not serum IgE levels), and reduced IL-1α and TNFα activation, despite on-going hapten challenges. Conclusion These results suggest that topical applications of certain activators/ligands of PPARα, β/δ, and LXR could be useful for the treatment of AD in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2009.06.049

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 88

Metadata

Authors
Hatano, Y., Man, M.-Q., Uchida, Y., Crumrine, D., Mauro, T. M., Feingold, K. R., Elias, P. M., & Holleran, W. M.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2010-01
Volume
125
Issue
1
Pages
160-169.e5
ISSN
0091-6749 (ISSN-L)
OpenAlex
W1982848064
Cited by
88
References
3
FWCI
7.06
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.